July 13, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Recently I saw a patient with Down syndrome on whom I had performed bilateral corneal cross-linking 5 years ago. This young woman, now 28 years old, is engaged to be married, works in a bridal shop and has been enjoying increasing independence. She has a zest for life that I know could so easily have been compromised or limited by visual impairment if we had not caught her keratoconus and treated
July 13, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

An epithelium-off corneal cross-linking treatment has been approved in the U.S. for nearly a decade.During that time, we have…

Patients who underwent corneal cross-linking for keratoconus had a temporary but statistically significant increase in IOP in the…

Find the latest Refractive Surgery news articles, videos, podcasts, and meeting coverage from medical experts and key opinion…

Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched…

Epioxa, an epithelium-on corneal collagen cross-linking therapy, made a significant and clinically meaningful difference in…

HELSINKI — As technology evolves, there is potential to quantify and automate presbyopia-correcting IOL selection through…